Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allo-HSCT
NCT01959100Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
azithromycin
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01959100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959100.